Screening in serum-derived medium reveals differential response to compounds targeting metabolism

Area of Science:

• Oncology
• Biochemistry
• Drug Discovery

Background:

• Cancer drug efficacy in cell culture models often fails to predict patient outcomes.
• Standard cell culture uses non-physiological nutrient levels, impacting cancer cell metabolism and drug sensitivity.
• A comprehensive understanding of how physiological nutrients influence cancer cell response to small molecule therapies is needed.

Approach:

• Developed a novel serum-derived culture medium supporting diverse cancer cell line proliferation.
• Adapted the system for high-throughput screening of small molecule libraries.
• Compared drug efficacy in standard versus serum-derived media to identify nutrient-dependent effects.

Key Points:

• Compounds targeting metabolic enzymes showed differential efficacy between standard and serum-derived media.
• Investigated nutrient-specific mechanisms underlying observed drug response variations.
• Demonstrated the utility of the system for screening therapeutics and understanding nutrient-mediated efficacy modulation.

Conclusions:

• Physiological nutrient availability significantly impacts cancer cell response to small molecule therapies.
• The developed serum-derived medium facilitates robust screening for nutrient-dependent drug efficacy.
• This approach enhances the predictive power of preclinical cancer drug screening.